Oliver Lagore Vanvalin Investment Group Makes New Investment in Agilent Technologies, Inc. $A

Key Points

• Oliver Lagore Vanvalin Investment Group purchased a new stake of 7,399 shares in Agilent Technologies, valued at approximately $866,000, during the second quarter.
• Agilent Technologies reported $1.74 billion in revenue for the latest quarter, exceeding analyst estimates of $1.67 billion, with an earnings per share of $1.37.
• The company declared a quarterly dividend of $0.248 per share, to be paid on October 22nd, representing an annualized yield of 0.8%.

Oliver Lagore Vanvalin Investment Group acquired a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 7,399 shares of the medical research company's stock, valued at approximately $866,000.

A number of other hedge funds have also recently made changes to their positions in A. Valeo Financial Advisors LLC boosted its stake in Agilent Technologies by 3.0% during the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company's stock valued at $403,000 after buying an additional 102 shares during the last quarter. Cary Street Partners Financial LLC boosted its stake in Agilent Technologies by 2.9% during the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company's stock valued at $431,000 after buying an additional 103 shares during the last quarter. Western Pacific Wealth Management LP boosted its stake in Agilent Technologies by 15.2% during the first quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company's stock valued at $102,000 after buying an additional 115 shares during the last quarter. Bartlett & CO. Wealth Management LLC raised its position in Agilent Technologies by 5.1% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company's stock valued at $281,000 after purchasing an additional 116 shares during the period. Finally, Brighton Jones LLC raised its position in Agilent Technologies by 2.6% during the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company's stock valued at $560,000 after purchasing an additional 121 shares during the period. Institutional investors own 87.41% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on A shares. TD Cowen upped their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. UBS Group decreased their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Wells Fargo & Company increased their price target on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a report on Monday, September 15th. Evercore ISI reduced their price target on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a report on Thursday, August 28th. Finally, Robert W. Baird increased their price target on Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a report on Thursday, August 28th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $140.08.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.26% of the company's stock.

Agilent Technologies Stock Up 0.0%

Shares of Agilent Technologies stock traded up $0.04 during trading on Monday, reaching $126.36. The company's stock had a trading volume of 976,298 shares, compared to its average volume of 1,944,656. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The company has a market cap of $35.82 billion, a price-to-earnings ratio of 29.66, a P/E/G ratio of 3.93 and a beta of 1.24. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a 50-day simple moving average of $120.25 and a two-hundred day simple moving average of $115.81.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies's payout ratio is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.